T. Rowe Price Associates’s CBIZ CBZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
59,348
+10,742
+22% +$379K ﹤0.01% 1935
2025
Q4
$2.45M Buy
48,606
+2,733
+6% +$144K ﹤0.01% 1663
2025
Q3
$2.43M Sell
45,873
-363,392
-89% -$23.4M ﹤0.01% 1649
2025
Q2
$29.4M Sell
409,265
-176,543
-30% -$12.8M ﹤0.01% 872
2025
Q1
$44.4M Sell
585,808
-63,506
-10% -$5.11M 0.01% 756
2024
Q4
$53.1M Sell
649,314
-109,196
-14% -$8.16M 0.01% 734
2024
Q3
$51M Sell
758,510
-19,059
-2% -$1.38M 0.01% 752
2024
Q2
$57.6M Sell
777,569
-50,630
-6% -$3.83M 0.01% 679
2024
Q1
$65M Sell
828,199
-6,509
-0.8% -$453K 0.01% 653
2023
Q4
$52.2M Sell
834,708
-27,091
-3% -$1.53M 0.01% 698
2023
Q3
$44.7M Sell
861,799
-29,626
-3% -$1.6M 0.01% 719
2023
Q2
$47.5M Buy
891,425
+38,770
+5% +$1.99M 0.01% 722
2023
Q1
$42.2M Buy
852,655
+175,133
+26% +$8.44M 0.01% 724
2022
Q4
$31.7M Buy
677,522
+81,942
+14% +$3.89M 0.01% 792
2022
Q3
$25.5M Buy
595,580
+53,565
+10% +$2.34M ﹤0.01% 839
2022
Q2
$21.7M Buy
542,015
+507,190
+1,456% +$20.5M ﹤0.01% 1146
2022
Q1
$1.46M Buy
34,825
+2,487
+8% +$97.4K ﹤0.01% 1820
2021
Q4
$1.26M Sell
32,338
-858
-3% -$32K ﹤0.01% 1916
2021
Q3
$1.07M Sell
33,196
-1,314
-4% -$42.8K ﹤0.01% 2032
2021
Q2
$1.13M Buy
34,510
+652
+2% +$21.8K ﹤0.01% 2022
2021
Q1
$1.11M Sell
33,858
-4,916
-13% -$145K ﹤0.01% 2009
2020
Q4
$1.03M Sell
38,774
-9,078
-19% -$223K ﹤0.01% 1924
2020
Q3
$1.09M Sell
47,852
-16,704
-26% -$397K ﹤0.01% 1760
2020
Q2
$1.55M Buy
64,556
+788
+1% +$17.9K ﹤0.01% 1612
2020
Q1
$1.33M Buy
63,768
+4,202
+7% +$107K ﹤0.01% 1610
2019
Q4
$1.61M Buy
59,566
+2,038
+4% +$53K ﹤0.01% 1686
2019
Q3
$1.35M Buy
57,528
+304
+0.5% +$6.83K ﹤0.01% 1685
2019
Q2
$1.12M Buy
57,224
+1,800
+3% +$36.1K ﹤0.01% 1804
2019
Q1
$1.12M Sell
55,424
-9,548
-15% -$193K ﹤0.01% 1792
2018
Q4
$1.28M Buy
64,972
+14,595
+29% +$312K ﹤0.01% 1706
2018
Q3
$1.19M Sell
50,377
-189
-0.4% -$4.38K ﹤0.01% 1798
2018
Q2
$1.16M Buy
50,566
+55
+0.1% +$1.11K ﹤0.01% 1780
2018
Q1
$922K Buy
50,511
+100
+0.2% +$1.74K ﹤0.01% 1827
2017
Q4
$779K Buy
50,411
+1,600
+3% +$25.2K ﹤0.01% 1902
2017
Q3
$793K Hold
48,811
﹤0.01% 1893
2017
Q2
$732K Hold
48,811
﹤0.01% 1911
2017
Q1
$661K Buy
48,811
+36
+0.1% +$484 ﹤0.01% 1956
2016
Q4
$668K Hold
48,775
﹤0.01% 1929
2016
Q3
$546K Hold
48,775
﹤0.01% 1984
2016
Q2
$508K Buy
48,775
+10,612
+28% +$109K ﹤0.01% 1960
2016
Q1
$385K Buy
38,163
+1,819
+5% +$18.4K ﹤0.01% 2073
2015
Q4
$358K Buy
36,344
+11,399
+46% +$121K ﹤0.01% 2090
2015
Q3
$245K Buy
24,945
+50
+0.2% +$488 ﹤0.01% 2215
2015
Q2
$240K Buy
24,895
+946
+4% +$8.84K ﹤0.01% 2282
2015
Q1
$223K Buy
23,949
+2,393
+11% +$20.9K ﹤0.01% 2318
2014
Q4
$185K Buy
21,556
+528
+3% +$4.56K ﹤0.01% 2373
2014
Q3
$165K Buy
21,028
+1,264
+6% +$10.8K ﹤0.01% 2388
2014
Q2
$178K Buy
19,764
+1,903
+11% +$16.6K ﹤0.01% 2376
2014
Q1
$164K Buy
17,861
+611
+4% +$5.48K ﹤0.01% 2366
2013
Q4
$157K Hold
17,250
﹤0.01% 2361
2013
Q3
$128K Hold
17,250
﹤0.01% 2357
2013
Q2
$116K Buy
+17,250
New +$112K ﹤0.01% 2312

Other funds holding CBZ

T. Rowe Price Associates's CBZ Position: Q1 2026 in Review

T. Rowe Price Associates increased its CBIZ (CBZ) stake by 22% in Q1 2026, buying an estimated $379K and bringing the position to 59,348 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

T. Rowe Price Associates first reported a position in CBZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $65M in Q1 2024. 263 funds tracked by Wall St. Rank hold CBZ as of Q1 2026.

  • T. Rowe Price Associates held 59,348 shares of CBIZ worth $1.59M as of Q1 2026.
  • T. Rowe Price Associates bought 10,742 CBIZ shares in Q1 2026, an estimated $379K.
  • CBIZ made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1935 holding.
  • T. Rowe Price Associates first reported a position in CBIZ in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's CBIZ position peaked at $65M in Q1 2024.
  • 263 funds tracked by Wall St. Rank held CBIZ as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.